Showing posts sorted by date for query LUNG CANCER. Sort by relevance Show all posts
Showing posts sorted by date for query LUNG CANCER. Sort by relevance Show all posts

Saturday, October 17, 2026

 

Exercise is good for us—but why?



Salk Institute researchers introduce a molecular atlas of exercise-associated changes in mice, defining the healthy, exercised-trained state, which could help improve performance and prevent injury



Salk Institute

Manoj Hariharan, Geraldine Maier, and Ramesh Ramasamy

image: 

Manoj Hariharan (left), Geraldine Maier (center), and Ramesh Ramasamy (right) debuted a molecular atlas of exercise-associated changes in mice, defining the healthy, exercised-trained state, which could help improve performance and prevent injury.

view more 

Credit: Salk Institute





LA JOLLA (October 15, 2026)—To understand what goes wrong in the body, scientists must first know what right looks like. Salk Institute researchers are building a scientific reference, piece by piece, for what makes a body healthy. Their latest effort maps how exercise reshapes the body at the molecular level, examining responses across organs, cell types, sexes, and circadian phases in mice.

The result is a first-of-its-kind molecular atlas spanning 22 tissues and integrating bulk RNA sequencing, metabolomics, proteomics, single-nucleus RNA sequencing, and DNA methylation profiling. The researchers uncovered distinct responses to exercise that vary by tissue, cell type, sex, and circadian categories. By defining a healthy baseline, the atlas gives scientists a starting point to explore how tissues adapt to exercise, work toward more personalized exercise strategies, and identify new molecules and pathways for further investigation.

The study was published in Cell on October 15, 2026, and was funded by both federal research grants and private philanthropy.

What do we know about exercise?

It’s no surprise that exercise is good for you—we hear it all the time. Exercise can make us resilient against disease and dysfunction, speed up recovery from illness, and reduce mortality overall. In fact, studies have linked exercise to more than 30 percent lower all-cause, cardiovascular, and cancer mortalities.

Despite knowing all the good that exercise can do, scientists have had a hard time deciphering why. This question has been difficult to answer, in part because studies in humans are limited to blood and a few muscles. As a result, mouse models have become a popular tool for determining the molecular signatures of exercise.

The Salk research team compared young male and female mice that either spent eight weeks running voluntarily on a wheel or were sedentary. They collected 22 tissue samples, during both active and resting time of the day.

“Exercise doesn’t just change our muscles, it changes many of our organs and cells at different levels—some short-term, some long-term,” says co-first and co-corresponding author Geraldine Maier, PhD, a staff scientist at Salk. “Our experimental setup allows us to capture that detail across tissues, and sexes, and in muscle, down to the individual cell types.”

How do you build an exercise atlas?

After collecting various tissues from sedentary and running mice, the researchers started with bulk RNA sequencing on all 22 tissues. Bulk RNA sequencing reveals which genes are active in each tissue. Then, they conducted metabolomics on eight tissues and plasma, which catalogs the small molecules that cells use and produce by cellular metabolism. Next was proteomics, which measures the protein levels in a certain tissue—in this case, the researchers looked at four specific leg muscles (a hamstring muscle, two calf muscles, and quadriceps).

After discovering that leg muscles had the biggest responses to exercise at the whole-tissue level, they used single-cell RNA and DNA methylation in three leg muscles. Rather than generalizing over the whole tissue, single-cell inquiry provides specific detail that differentiates neighboring cells by their precise identities and activities.

The Salk study is the first to conduct single-cell methylation work on muscle after exercise. Methylation is a type of epigenetic change that regulates the expression of genes. Compared to differences in protein or RNA expression, exercise-induced changes in DNA methylation are more permanent. Methylation can lead to lasting regulatory changes that alter cell type and whole-tissue behavior.

In addition to creating the atlas, the researchers used the transcriptomic dataset to develop a 51-gene exercise signature that distinguishes exercise-trained from sedentary muscle in both mice and humans. This signature could help to identify biomarkers and study muscle disuse and dysfunction.

How does exercise change living systems, on a molecular scale?

The atlas first revealed that exercise induced widespread, tissue-specific cellular remodeling—with most transcriptional changes occurring in skeletal muscle. Exercise changed the activity of nearly half the genes in at least one tissue, yet no single gene’s activity was changed in all 22 tissues. And in muscle, exercise altered methylation in specific cell types but not others. These findings especially demonstrate the power of single-cell-level analyses, as these details would have been missed in bulk sequencing.

When looking at differences across circadian phases, the team noted that most tissues changed more during the active phase, excluding the hypothalamus, kidney, and lung. When looking at sex-based differences, females had broader transcriptional responses and distinct gene expression patterns compared to males. There was also a strong sex-specific epigenetic response to training.

“Our atlas provides a comprehensive resource for understanding the systemic molecular adaptations to endurance exercise,” says co-first author Ramesh Ramasamy, PhD, a former computational biologist at Salk. “Now that we have all this data, researchers can begin developing strategies that harness exercise—either alone or in combination with other interventions—to ensure we all live long, healthy lives.”

What can an exercise atlas be used for?

The atlas is a starting point toward creating exercise routines tailored to individuals, since responses differ by sex and time of day. It also provides the data needed for more targeted research within specific tissues and cell types, which could potentially point to new biomarkers or strategies for improving performance, recovery, and muscle health.

“Now that we have the data,” adds Maier, “labs can identify one gene or metabolic pathway they find interesting then dissect that mechanism. Our atlas gives the field a shared foundation to build on.”

“Exercise impacts the whole body, not just your muscles, so an atlas like ours that looks more holistically at many tissues is key to understanding the true impact of exercise,” says co-first author Manoj Hariharan, PhD, a former senior staff scientist at Salk. “That’s also why single-cell studies are so important—there are so many cell type-specific changes that get lost in bulk sequencing. I hope our work highlights that and encourages more single-cell atlases, and especially multi-omic single-cell atlases, moving forward.”

Further research will need to explore how “sticky” exercise-induced changes are. How long do you have to exercise to see lasting change? How long do those changes last? Do cells remember exercising after months? Years?

An atlas marks the beginning of an endeavor that can go on for decades. With new data come new questions and new discoveries, each bringing us closer to understanding human health and how we can protect it.

Other information and funding

The work was supported by the Wu Tsai Human Performance Alliance; Joe and Clara Tsai Foundation; National Institutes of Health (S10 OD026929, P30 014195, HG010634); Chapman Foundation; Helmsley Charitable Trust; Ministry of Education, Culture, Sports, Science and Technology in Japan; Veterans Administration; National Science Foundation (2138259, 2138286, 2138307, 2137603, 2138296); and Howard Hughes Medical Institute.

This press release was written by Isabella Davis.

Journal: Cell

Paper title: Multi-omics atlas of chronic exercise

DOI: 10.1016/j.cell.2026.09.044

About the Salk Institute for Biological Studies

The Salk Institute is an independent, nonprofit research institute founded in 1960 by Jonas Salk, developer of the first safe and effective polio vaccine. The Institute’s mission is to drive foundational, collaborative, risk-taking research that addresses society’s most pressing challenges, including cancer, Alzheimer’s disease, and crop resilience. This foundational science underpins all translational efforts, generating insights that enable new medicines and innovations worldwide. Learn more at www.salk.edu.

 

What makes us human? A first atlas of functional DNA changes offers new clues



Researchers identify evolutionary DNA changes that shaped the human skeleton and may help explain degenerative skeletal diseases, such as osteoarthritis




McGill University





A new genetic atlas is helping scientists trace the DNA changes that transformed a shared primate ancestor into modern humans.

For the first time, researchers can systematically test which genetic differences between humans and chimpanzees affect gene activity.

The study, published in Nature, grew out of a collaboration among researchers at McGill University, Kyoto University and the Weizmann Institute of Science.

“Human and chimpanzee genomes are more than 98 per cent identical, but until now we had no way to know which genetic differences had meaningful biological effects,” said first author Yizhi Yan, a PhD student in the Kyoto-McGill International Collaborative Program in Genomic Medicine.

Understanding those changes could reveal not only how humans evolved, but also why some diseases arise in the first place.

Insights into skeletal development and disease

As a first test of the atlas, researchers examined the effect of hundreds of thousands of DNA differences on gene expression in skeletal cells.

“We were surprised to find that thousands of genetic changes appeared to have meaningful effects. That opens up a wealth of new avenues for future research,” said co-author Guillaume Bourque, Professor in McGill's Department of Human Genetics and Distinguished Visiting Professor at Kyoto University.

Researchers then narrowed the field to genes linked to cartilage development.

Their analysis suggests humans evolved to have lower levels of molecules that help cartilage retain water and withstand pressure than do other great apes.

While this shift may have helped shape distinctive features of the human skeleton, it may also help explain why humans are particularly vulnerable to some skeletal disorders.

Evolutionary trade-off

The finding points to an evolutionary trade-off, the authors note.

“The genetic changes that gave humans new traits may also have created new vulnerabilities. Understanding those trade-offs can help us understand why some diseases exist today,” said Bourque.

In the case of the skeleton, that could mean a better understanding of conditions affecting cartilage and bone, including osteoarthritis and osteoporosis, he added.

The team is now looking to apply the same approach to cells from other parts of the body, notably the brain, where the atlas could shed new light on the evolution of human cognition.

About the study

“The gene-regulatory evolution of the human skeleton” by Yizhi Yan, Guillaume Bourque, Fumitaka Inoue and David Gokhman et al., was published in Nature. Funding for the study was provided by research agencies and foundations in Europe, Israel, Japan and Canada, including the European Research Council, Japan's Ministry of Education, Culture, Sports, Science and Technology (MEXT), the Israel Science Foundation and the Leakey Foundation.

Wednesday, October 14, 2026

 

Long-term viral hepatitis control and changing patterns of liver cancer mortality in Japan




Hiroshima University
Long-term trends in cancer-specific mortality in Japan between 1958 and 2022, by sex

image: 

Long-term trends in cancer-specific mortality in Japan between 1958 and 2022, by sex. Mortality rates for major cancers among males and females, including liver (blue, including both viral- and non-viral-related liver cancer), stomach (orange), pancreatic (grey), lung (yellow), colon (black), breast (light blue), and uterine cancers (green). Liver cancer mortality increased until the early 2000s and subsequently declined, contrasting with continuing increases in mortality from several other major cancers. (Junko Tanaka, et al. The Lancet Regional Health - Western Pacific. August 17, 2026) 

view more 

Credit: Junko Tanaka, et al. The Lancet Regional Health - Western Pacific. August 17, 2026






Over decades of sustained, integrated national viral hepatitis control, Japan has seen substantial reductions in HBV- and HCV-related disease burden and hepatocellular carcinoma mortality.

Chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are major causes of liver cirrhosis and hepatocellular carcinoma (HCC). Due to the public health burden of viral hepatitis, Japan enacted systematic, nationwide countermeasures, starting with improvements in blood safety and reductions in healthcare-associated transmission (from the 1970s onward); prevention of mother-to-child transmission (from 1986 onwards); and institutionalization of hepatitis control through legal and financial frameworks and expanded access to antiviral treatment (from the 2000s onwards).

A review paper by a research team at Hiroshima University investigated how coordinated policy frameworks and robust epidemiological infrastructure have been associated with reductions in viral hepatitis–related HCC in Japan, and what gaps remain toward achieving hepatitis elimination. In doing so, they highlight transferable lessons for countries seeking to eliminate viral hepatitis.

The review was published in the journal The Lancet Regional Health - Western Pacific on August 17, 2026.

“This study examines how the epidemiology of viral hepatitis and liver cancer in Japan has changed over nearly five decades of national hepatitis control measures, and what challenges remain as the country approaches the WHO 2030 hepatitis elimination targets,” says Tomoyuki Akita, lecturer at Hiroshima University’s Graduate School of Biomedical and Health Sciences. “Understanding the long-term population impact of [Japan’s viral hepatitis control] measures is important not only for evaluating Japan’s progress toward hepatitis elimination, but also for identifying the next priorities for liver cancer prevention.”

The researchers collected peer-reviewed research articles related to HCC, liver cancer, viral hepatitis, liver cirrhosis, and Japan, published between January 1970 and January 2026, through online searches of the PubMed database. They also manually searched government reports for additional sources, included data from their Epidemiological Research Group on Viral Hepatitis and its Long-term Course (VH-Epi), and incorporated data from national vital statistics and multiple large-scale statistics and surveillance databases.

Decades of hepatitis control have brought Japan closer to elimination ...

The prevalence of HBV and HCV has fallen drastically across Japan. In first-time blood donors—generally considered a healthy population—Hepatitis B surface antigen (HBsAg, a positive marker of HBV infection) fell from 0.63% in 1995–2000 to 0.13% in 2017–2021; in the same period, HCV antibody (anti-HCV, a positive marker of HCV infection) fell from 0.49% to 0.16% over the same periods. Among residents aged ≥40 years at health checkups, HBsAg fell from 1.16% in 2002 to 0.55% in 2021, while anti-HCV fell from 1.16% to 0.21% in the same period. The incidence of newly acquired HBV and HCV infections in blood donors representing historically low levels in Japan, at 2.38 per 100,000 person-years for HBV and 0.4 per 100,000 person-years for HCV.

“One particularly striking finding is that among pregnant women born in or after 2000, HBsAg-positive individuals have become extremely rare, illustrating the intergenerational impact of Japan’s HBV mother-to-child transmission prevention program since 1986,” says Akita.

Viral hepatitis remains an important concern among several high-risk populations in Japan, including persons who inject drugs (PWID), men who have sex with men (MSM), migrants from regions where HBV is endemic, and incarcerated populations. Addressing viral hepatitis among these populations remains an important challenge as Japan moves toward elimination.

... while reshaping the landscape of liver cancer

At the same time, the decline in viral hepatitis-related HCC has reshaped the relative distribution of liver cancer causes in Japan. The proportion of HCC deaths attributed to non-viral causes increased from 6.8% in 1992 to 56.0% in 2019. This shift largely reflects the substantial decline in viral hepatitis-related HCC, rather than a comparable increase in the absolute burden of non-viral HCC. “In other words,” Akita says, “more than half of hepatocellular carcinoma deaths in Japan are now attributable to non-viral causes—a dramatic reversal from the era when viral hepatitis dominated the country’s liver cancer burden.”

Non-viral causes include alcohol-related liver disease and metabolic dysfunction-associated steatotic liver disease (MASLD). As Japan approaches viral hepatitis elimination, maintaining the achievements of hepatitis control remains essential, while liver cancer prevention will also need to address these emerging non-viral causes. “Japan’s long-term, integrated hepatitis control strategy has substantially reduced HBV and HCV infections and related liver cancer deaths, bringing the country closer to hepatitis elimination,” Akita says. “The next step is to achieve and sustain viral hepatitis elimination while adapting liver cancer prevention to Japan’s changing disease landscape.”

The study was co-authored by Junko Tanaka, Ko Ko, Aya Sugiyama, Chanroth Chhoung, Akemi Kurisu and Tomoyuki Akita at Hiroshima University; Masahiro Satake at the Japanese Red Cross; and Tatsuya Kanto and Takaji Wakita at the Japan Institute for Health Security. Junko Tanaka and Tomoyuki Akita are corresponding authors.

This work was supported by the Ministry of Health, Labour and Welfare (MHLW) Policy Research for Hepatitis Measures Program (JPMH 22HC1001, JPMH 25HC1001).

###

About Hiroshima University 
Since its foundation in 1949, Hiroshima University has striven to become one of the most prominent and comprehensive universities in Japan for the promotion and development of scholarship and education. Consisting of 12 schools for undergraduate level and 5 graduate schools, ranging from natural sciences to humanities and social sciences, the university has grown into one of the most distinguished comprehensive research universities in Japan. English website: https://www.hiroshima-u.ac.jp/en